Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Pfizer Inc share price to rise to 38.30 in the next year from the last price of 24.95.
High53.5%38.30
Med53.5%38.30
Low53.5%38.30

Dividends

Dividend information is not available for Pfizer Inc.
Div growth (TTM)2.50%
More ▼

Earnings history & estimates in USD

On Jan 31, 2017, Pfizer Inc reported 4th quarter 2016 earnings of 0.47 per share. This result was in line with the consensus of the 12 analysts following the company and under-performed last year's 4th quarter results by 11.32%.
Average growth rate-1.43%
Pfizer Inc reported annual 2016 earnings of 2.40 per share on Jan 31, 2017.
Average growth rate+2.40%
More ▼

Revenue history & estimates in USD

-32768 had 4th quarter 2016 revenues of 13.63bn. This missed the 13.67bn consensus estimate of the 12 analysts following the company. This was 25.43% above the prior year's 4th quarter results.
Average growth rate-0.66%
-32768 had revenues for the full year 2016 of 52.82bn. This was 8.13% above the prior year's results.
Average growth rate-2.43%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.